MSD CVD 2014

I D ENTI F YI N G AN D M ANAG I N G PATI ENTS AT

HIGH W H Y S H O U L D W E B OT H ER? tary, n e m i y pl Com tive, 1-da c intera shops for work ssionals profe g in the g in work are settin c ary prim

12 November 2013 London 23 January 2014 Birmingham

Who should attend:

GPs, GPSIs in cardiology or diabetes, diabetes specialist nurses, cardiac specialist nurses, nurse practitioners, nurse consultants, pharmacists with an interest in cardiovascular disease or diabetes, prescribing leads, clinical leads and commissioning managers

B O O K

YO U R

CO M P L I M EN TA RY

P L AC E

Why attend: An easy way to bring yourself up to date Interactive case-based learning on the hot topics affecting cardiovascular disease risk assessment and management Complimentary workbook and post-event online resources to meet revalidation requirements

Fully funded by MSD and developed in conjunction with SB Communications Group.

TO DAY

AT:

www.diabetesonthenet.com/events Date of preparation: July 2013 Job code: CARD-1089861-0002

I D ENTI F YI N G AN D M ANAG I N G PATI ENTS AT

HIGH

Th con is meet side ing high r the fo will llo -risk grou wing • Ty ps: pe 2 • Im diab pair etes ed r ena l fun hyp • Fa ction erch mili oles al tero • Pr laem ior s ia • Pr trok e ior m infa yocar rctio dial n

W H Y S H O U L D W E B OT H ER? PROGRAMME PLANNING COMMITTEE Beverley Bostock-Cox, Nurse Practitioner and Lead Nurse, Sky Blue Medical Group, Coventry

Partha Kar, Clinical Director, Diabetes and Endocrinology, Portsmouth Hospitals NHS Trust

Mike Kirby, GP, Letchworth, Hertfordshire and Visiting Professor, Faculty of Health and Human Sciences, University of Hertfordshire

Adie Viljoen, Consultant Chemical Pathologist and Lipidologist, Lister Hospital, East and North Hertfordshire NHS Trust

ADDITIONAL SPEAKERS INCLUDE: Michael Cummings, Consultant Physician and Professor of Diabetes and Endocrinology, Portsmouth Hospitals NHS Trust

Michael Norton, Consultant Community Cardiologist, South Tyneside NHS Foundation Trust

I

t will come as no surprise to you that cardiovascular disease (CVD) is one of the major causes of premature mortality in many European countries.1 In recent decades, reductions in rates of CVD have been observed in a number of parts of the globe, and as such it is clear that preventative measures can certainly be effective.1 But how should we, as professionals working in the NHS, go about minimising rates of CVD in those at the highest levels of risk? And indeed, are we clear on how to identify those at high risk in the first instance?

In a mix of expert lectures, interactive case scenarios and quick-fire updates, our speakers will provide a very practical guide to the identification and management of high-risk patient groups. On the day, as well as taking part in the sessions and networking, you will have the opportunity to vote for the specific case scenarios you would like to see featured.

In addition, you will be able to take away a workbook to help you record your key learning points and translate them to your dayto-day work, helping you meet revalidation or personal development requirements.

We hope you can join us in either London or Birmingham for what is promising to be a useful and progressive learning opportunity – please book your place now to avoid disappointment!

The programme planning committee 1. Perk J et al (2012) Eur Heart J 33: 1635–701

PROGRAMME 09.10–09.50

Registration

SESSION 1.

CVD RISK ASSESSMENT AND MANAGEMENT: WHO IS AT HIGH RISK AND WHY? HOW SHOULD WE INTERVENE?

09.50–10.00

Session chair’s welcome

10.00–10.40

10.40–11.20

“The who”: Which patients are at high risk of CVD, and how do we find them?

• Practicalities of CVD risk assessment in primary care • Getting a clear picture of the “high risk” patient: post-myocardial infarction and post-stroke patients, and those with type 2 diabetes, chronic kidney disease or familial hypercholesterolaemia • Top tips for identifying high risk patients in clinical practice

“The why”: The science and the politics behind CVD risk management – data and documentation

• Understanding the reasons why each high-risk group is at high risk: what do we know?

• Evidence regarding targets for CVD risk factors and “lower is better” – why do some guidelines advocate cholesterol targets of “4 or 2”, for example?

• What are the implications of not hitting the targets and “making do” with achieving QOF indicators?

11.20–12.00

“The how”: Top tips in managing the high risk or complex CVD patient

• Lifestyle interventions: what works in practice?

• The importance of a multifactorial approach and keys to success • Addressing the elephant in the room: what can we really do to improve treatment concordance?

12.00–13.00

Lunch

SESSION 2.

PUTTING CVD RISK MANAGEMENT INTO PRACTICE: CLINICAL, POLITICAL AND FINANCIAL ASPECTS

13.00–13.05

Session chair’s welcome

13.00–14.30 Delegates vote on which cases they would like to see discussed

Practical conundrums in CVD risk management: Case scenarios

1 A person with type 2 diabetes and CVD: what went wrong and when?

2 What to do when local and national guidelines aren’t congruent?

3 Why did a policy of statin switching lead to increased hospitalisation rates?

4 What to prescribe and when in the case of hypercholesterolemia, diabetes and impaired renal function?

5 How to deal with muscle pains with statin therapy?

6 Pain and peripheral arterial disease: what’s going on?

7 Erectile dysfunction: how to ask the question and what to do with the answer?

8 When is a statin not appropriate?

• Each case will be followed by opinions from a GP, consultant physician, nurse and clinical commissioner

14.30–15.00

Tea and coffee

SESSION 3.

HOT TOPICS IN CVD RISK MANAGEMENT: A QUICK-FIRE UPDATE

15.00–15.20

15.20–15.40

15.40–16.00

16.00–16.20

What’s new in lifestyle approaches to CVD risk?

• New data on the Mediterranean diet • Latest thinking on the role of exercise and physical activity • Practical tips regarding smoking cessation

What’s new in the management of hypertension?

• How low to go: is there a “J” shaped relationship between blood pressure and outcomes?

• New guidelines on the diagnosis and management of hypertension • What drugs might be around the corner?

What’s new in glucose therapy in relation to CVD outcomes in diabetes?

• Glycaemic targets and cardiovascular outcomes – conflict or clarity?

• Wrap up of latest trials for CVD outcomes with individual glucose lowering agents • What’s coming up in relation to CVD in diabetes?

What’s new in lipid management?

• Statins and diabetes risk: latest thinking • Recent lipid management trials: progress and possible practical implications • Drugs in development: modes of action and trial data

16.20–16.30

Session chair’s summary and close

16.30–17.00

Opportunity to discuss any “burning questions” one-to-one with speakers

I D EN T I F Y I N G A N D M A N AG I N G PAT I EN TS AT

HIGH

12 November 2013 London 23 January 2014 Birmingham

WHY SH O U L D WE BOT H ER?

B O O K

YO U R

CO M P L I M EN TA RY

P L AC E

TO DAY

AT:

www.diabetesonthenet.com/events To reserve your complimentary place please book online at: www.diabetesonthenet.com/events or complete this form and fax it to: 020 7627 1570. Please use BLOCK CAPITALS.

Please select the date and location you wish to attend: 12 November 2013, The Grand Connaught Rooms, London 23 January 2014, The National Motorcycle Museum, Birmingham

Title:

Post/job title:

Full name:

Place of work:

Correspondence address:

Postcode:

Special requests (e.g. dietary):

Daytime telephone:

Daytime fax:

Email address: Confirmation will be sent by email Please tick this box if you would like to receive updates from MSD containing promotional information on disease areas relevant to this meeting and their treatment I would like to receive a visit from an MSD representative to discuss disease areas relevant to this meeting and their treatment.

Your data is being collected by SB Communications Group on behalf of MSD solely for the purposes of processing your registration and (depending on your choices above) communicating further information to you. Your details will not be shared with any parties other than SB Communications Group and MSD.

Completed booking forms should be posted or faxed to: The events team, SB Communications Group, 1.03 Enterprise House, 1–2 Hatfields, London, SE1 9PG Tel: 020 7627 1510 Fax: 020 7627 1570 Email: bookings@sbcommunicationsgroup.com Online booking available at: www.diabetesonthenet.com/events

Fully funded by MSD and developed in conjunction with SB Communications Group.

Date of preparation: July 2013 Job code: CARD-1089861-0002